USPTO serial 79265537
MIDASOLVE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 5, 2021
- Examiner
- FLETCHER,TRACY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MIDASOLVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Manuel Valcarcel, Esq.
Manuel Valcarcel, Esq. Greenberg Traurig, P.A.333 S.E. 2nd Avenue, 44th FloorMiami, FL 33131UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Nano-particle ingredients, namely, nanoparticle chemical compounds for use in the manufacture of pharmaceuticals, medicines and cosmetics; macrocylic chemicals used as solubilising and stabilising agents for use in manufacturing pharmaceuticals, medicines and cosmetics | ACTIVE | — |
| 005 | Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals and medicines; nano-particles for use as carriers sold as an integral component of pharmaceutical preparations and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system and central nervous system related diseases and disorders; nano-particles for use as carriers sold as an integral component of medicated cosmetics | ACTIVE | — |
| 040 | Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices to the order and specification of others; custom manufacture of drug delivery agents for facilitating delivery of pharmaceuticals and medicines; custom manufacture of macrocylic compounds, compositions and derivates used as solubilising and stabilising agents for use in further manufacture of pharmaceuticals, medicines and cosmetics | ACTIVE | — |
| 042 | Scientific research services in the field of nano-particle technology; pharmaceutical and drug research, development and discovery services; drug delivery agent research, development and discovery services; testing and advisory services related to research and product design in the field of nano-particles, macro-cyclic compounds, pharmaceuticals and nano-medicine; nano-particle laboratory research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Midatech Limited
- Other trademarks owned by Midatech Limited
- Other trademarks owned by Midatech Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named MIDASOLVE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 2, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 12, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 12, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 5, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 20, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 18, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 30, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 30, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 30, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 16, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 27, 2020 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Mar 27, 2020 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Mar 27, 2020 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Mar 26, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 26, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 26, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 12, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 5, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 13, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 13, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 3, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 1, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 31, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |